Texas Tech University Health Science Center

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder	Recruiting	Phase 4	2026-08-03	NCT07611214
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age	Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder	Recruiting	Phase 3	2026-02-11	NCT06380517
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching	Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder	Recruiting	Phase 3	2026-02-11	NCT04378790

Clinical trials